# Nectero EAST System Clinical Study

Study · id `cardio:ct-nct06001918` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06001918](<https://clinicaltrials.gov/study/NCT06001918>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06001918

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT06001918. Randomized; single masking; primary purpose treatment. Start 2023-10-25 (actual); primary completion 2028-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT06001918, source copy `cardio:ctgov-nct06001918-2026-09-28`, retrieved 2026-11-18)
- Started: 2023-10-25 (actual) (ClinicalTrials.gov record NCT06001918, source copy `cardio:ctgov-nct06001918-2026-09-28`, retrieved 2026-11-18)
- Primary completion: 2028-06-30 (anticipated) (ClinicalTrials.gov record NCT06001918, source copy `cardio:ctgov-nct06001918-2026-09-28`, retrieved 2026-11-18)
- Completion: 2032-12-31 (anticipated) (ClinicalTrials.gov record NCT06001918, source copy `cardio:ctgov-nct06001918-2026-09-28`, retrieved 2026-11-18)
- Countries: United States; Australia; New Zealand (ClinicalTrials.gov record NCT06001918, source copy `cardio:ctgov-nct06001918-2026-09-28`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06001918-2026-09-28`, retrieved 2026-11-18)

## The registry's words

- Brief title: Nectero EAST System Clinical Study
- Acronym: stAAAble
- Condition: Abdominal Aortic Aneurysm
- Intervention (Drug): Nectero EAST System
- Lead sponsor: Nectero Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)

## Provenance

Content hash: 6ce63a2b8751a0d35a24235cf275b7346607dc46c004a28f079c7b5ff09d5945
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
